Even though Albumin has been used for decades, an almost inconceivable amount of controversy regarding its effectiveness exists. We are developing a protocol that prospectively examines albumin use within the first 48 hours of burn injury during burn shock resuscitation. Our goal is to better define how albumin really is given (what indication, formulation, rate) in the clinical scenario that reportedly (by our survey data) most often triggers its use.

Please contact Dr. Bruce Cairns if you have an interest in participating in the development of this protocol (or would like to take the survey that we have already given out).